Exact Mass: 461.4021

Exact Mass Matches: 461.4021

Found 24 metabolites which its exact mass value is equals to given mass value 461.4021, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Perifosine

1,1-dimethyl-4-{[(octadecyloxy)phosphinato]oxy}piperidin-1-ium

C25H52NO4P (461.3634)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C2188 - Alkylphosphocholine Compound C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer Perifosine is an oral Akt inhibitor which inhibits proliferation of different tumor cell lines with IC50s of 0.6-8.9 μM.

   

2-tricosanamidoethanesulfonic acid

2-tricosanamidoethanesulfonic acid

C25H51NO4S (461.3539)


   

NAT 23:0

N-tricosanoyl taurine

C25H51NO4S (461.3539)


   

Didodecyldimethylammonium bromide

Didodecyldimethylammonium bromide

C26H56BrN (461.3596)


   

Cholest-5-en-3-amine,N-phenyl-, (3b)-(9CI)

Cholest-5-en-3-amine,N-phenyl-, (3b)-(9CI)

C33H51N (461.4021)


   

2-(Tricosanoylamino)ethanesulfonic acid

2-(Tricosanoylamino)ethanesulfonic acid

C25H51NO4S (461.3539)


   

(8Z,11Z,14Z,17Z)-N-(1,3-dihydroxynonan-2-yl)icosa-8,11,14,17-tetraenamide

(8Z,11Z,14Z,17Z)-N-(1,3-dihydroxynonan-2-yl)icosa-8,11,14,17-tetraenamide

C29H51NO3 (461.3869)


   

(11Z,14Z,17Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]icosa-11,14,17-trienamide

(11Z,14Z,17Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]icosa-11,14,17-trienamide

C29H51NO3 (461.3869)


   

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxytridec-4-en-2-yl]hexadeca-7,10,13-trienamide

C29H51NO3 (461.3869)


   

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]octadeca-9,12,15-trienamide

(9Z,12Z,15Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]octadeca-9,12,15-trienamide

C29H51NO3 (461.3869)


   

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxytridecan-2-yl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxytridecan-2-yl)hexadeca-4,7,10,13-tetraenamide

C29H51NO3 (461.3869)


   

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxyundecan-2-yl)octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-(1,3-dihydroxyundecan-2-yl)octadeca-6,9,12,15-tetraenamide

C29H51NO3 (461.3869)


   

(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]heptadeca-9,12-dienamide

(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]heptadeca-9,12-dienamide

C29H51NO3 (461.3869)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tridec-9-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tridec-9-enamide

C29H51NO3 (461.3869)


   

(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]hexadeca-9,12-dienamide

(9Z,12Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]hexadeca-9,12-dienamide

C29H51NO3 (461.3869)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]tetradec-9-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]tetradec-9-enamide

C29H51NO3 (461.3869)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]pentadec-9-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]pentadec-9-enamide

C29H51NO3 (461.3869)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]dodec-5-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]dodec-5-enamide

C29H51NO3 (461.3869)


   

(Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tridec-8-enamide

(Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tridec-8-enamide

C29H51NO3 (461.3869)


   

Perifosine

Perifosine(KRX-0401)

C25H52NO4P (461.3634)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C2188 - Alkylphosphocholine Compound C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer Perifosine is an oral Akt inhibitor which inhibits proliferation of different tumor cell lines with IC50s of 0.6-8.9 μM.

   

NA-Dopamine 21:0

NA-Dopamine 21:0

C29H51NO3 (461.3869)


   

NA-Histamine 24:0

NA-Histamine 24:0

C29H55N3O (461.4345)


   

NA-Taurine 23:0

NA-Taurine 23:0

C25H51NO4S (461.3539)


   

(1r,3ar,3br,7r)-1,7-dihydroxy-1-[(2s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-9a-yl

(1r,3ar,3br,7r)-1,7-dihydroxy-1-[(2s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6-tetramethyl-dodecahydro-2h-cyclopenta[a]phenanthren-9a-yl

C29H49O4 (461.3631)